Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2010 3
2011 7
2012 4
2013 3
2014 2
2015 2
2016 4
2017 8
2018 9
2019 7
2020 13
2021 13
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.
Sormani MP, Inglese M, Schiavetti I, Carmisciano L, Laroni A, Lapucci C, Da Rin G, Serrati C, Gandoglia I, Tassinari T, Perego G, Brichetto G, Gazzola P, Mannironi A, Stromillo ML, Cordioli C, Landi D, Clerico M, Signoriello E, Frau J, Ferrò MT, Di Sapio A, Pasquali L, Ulivelli M, Marinelli F, Callari G, Iodice R, Liberatore G, Caleri F, Repice AM, Cordera S, Battaglia MA, Salvetti M, Franciotta D, Uccelli A; CovaXiMS study group on behalf of the Italian Covid-19 Alliance in MS. Sormani MP, et al. Among authors: laroni a. EBioMedicine. 2021 Oct;72:103581. doi: 10.1016/j.ebiom.2021.103581. Epub 2021 Sep 22. EBioMedicine. 2021. PMID: 34563483 Free PMC article.
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
Uccelli A, Laroni A, Brundin L, Clanet M, Fernandez O, Nabavi SM, Muraro PA, Oliveri RS, Radue EW, Sellner J, Soelberg Sorensen P, Sormani MP, Wuerfel JT, Battaglia MA, Freedman MS; MESEMS study group. Uccelli A, et al. Among authors: laroni a. Trials. 2019 May 9;20(1):263. doi: 10.1186/s13063-019-3346-z. Trials. 2019. PMID: 31072380 Free PMC article.
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, Cavalla P, Torri Clerici V, Ragonese P, Nociti V, Radaelli M, Laroni A, Buttari F, Lorefice L, Ferraro D, Gajofatto A, Prosperini L, Fantozzi R, Boffa L, Lanzillo R, Moccia M, Clerico M, De Luca G, Tomassini V, Calabrese M, Borrelli A, Paolicelli D, Maniscalco GT, Gazzola P, Gallo A, Solaro C, Cocco E, Gasperini C, Tortorella C; RIREMS (Rising Researchers in MS) group. Di Filippo M, et al. Among authors: laroni a. J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug 18. J Neurol Neurosurg Psychiatry. 2022. PMID: 34408003 No abstract available.
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.
Cellerino M, Boffa G, Lapucci C, Tazza F, Sbragia E, Mancuso E, Bruschi N, Minguzzi S, Ivaldi F, Poirè I, Laroni A, Mancardi G, Capello E, Uccelli A, Novi G, Inglese M. Cellerino M, et al. Among authors: laroni a. Neurotherapeutics. 2021 Oct;18(4):2579-2588. doi: 10.1007/s13311-021-01104-8. Epub 2021 Sep 22. Neurotherapeutics. 2021. PMID: 34553320 Free PMC article.
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives.
Celius EG, Thompson H, Pontaga M, Langdon D, Laroni A, Potra S, Bharadia T, Yeandle D, Shanahan J, van Galen P, Alexandri N, Kesselring J. Celius EG, et al. Among authors: laroni a. Patient Prefer Adherence. 2021 Jan 8;15:15-27. doi: 10.2147/PPA.S268829. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33447018 Free PMC article. Review.
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.
Gross CC, Schulte-Mecklenbeck A, Wiendl H, Marcenaro E, Kerlero de Rosbo N, Uccelli A, Laroni A. Gross CC, et al. Among authors: laroni a. Front Immunol. 2016 Dec 19;7:606. doi: 10.3389/fimmu.2016.00606. eCollection 2016. Front Immunol. 2016. PMID: 28066417 Free PMC article. Review.
Neuroprotective features of mesenchymal stem cells.
Uccelli A, Benvenuto F, Laroni A, Giunti D. Uccelli A, et al. Among authors: laroni a. Best Pract Res Clin Haematol. 2011 Mar;24(1):59-64. doi: 10.1016/j.beha.2011.01.004. Epub 2011 Feb 25. Best Pract Res Clin Haematol. 2011. PMID: 21396593 Review.
70 results